PEERLESS II Study RCT of FlowTriever vs. Anticoagulation Alone in Pulmonary Embolism
-
Enrollment
This study is currently enrolling. -
Research Area
Heart, Lung and Vascular Research -
Location
-
Principal Investigator
-
Sponsor
Inari Medical
You are being asked to take part in this study because you have a pulmonary embolism (PE). A PE is a blood clot trapped in your lung. You are being asked to participate in the PEERLESS II Study because your doctor may use either FlowTriever plus anticoagulation medicine or anticoagulation medicine alone to treat your pulmonary embolism.
Enrollment Form
This study is currently enrolling.